Last reviewed · How we verify
Concomitant administration
Concomitant administration refers to the simultaneous or concurrent use of multiple vaccines or drugs to evaluate their combined safety and immunogenicity profile.
Concomitant administration refers to the simultaneous or concurrent use of multiple vaccines or drugs to evaluate their combined safety and immunogenicity profile. Used for Evaluation of concurrent vaccine administration safety and immunogenicity.
At a glance
| Generic name | Concomitant administration |
|---|---|
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Therapeutic area | Immunology/Vaccines |
| Phase | Phase 3 |
Mechanism of action
This is not a drug itself, but rather a clinical trial design approach used by Sanofi Pasteur to assess how two or more vaccines or therapeutic agents perform when given together. The phase 3 trial evaluates whether co-administration affects the immune response, safety profile, or efficacy of the individual components compared to separate administration.
Approved indications
- Evaluation of concurrent vaccine administration safety and immunogenicity
Common side effects
Key clinical trials
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
- Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) (PHASE2)
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma (PHASE1)
- Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay (NA)
- Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients (NA)
- 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer (PHASE1, PHASE2)
- Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |